Internal Medicine · Portland, OR
NPI
1831681956
Since 2018
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
417 SW 117th Ave Ste 200
Portland, OR, 97225
Phone (503) 216-9400
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
2,026 services
Medicare patients, 2024
268
Average age 75
Drug cost, 2024
$78K
1,690 prescriptions
Company payments, 2025
$531
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julia P Speros was code 17003 (destruction skin lesion), 777 times for 129 patients. In total Julia P Speros billed 2,026 services in 43 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 777 | 129 | $4.51 | $3,504 |
| 99214 Office E&M - Established | Office | 263 | 176 | $72.75 | $19K |
| 17000 Destruction Skin Lesion | Office | 213 | 162 | $29.75 | $6,338 |
| 11102 Skin Biopsy | Office | 116 | 93 | $55.04 | $6,385 |
| 99213 Office E&M - Established | Office | 103 | 87 | $50.28 | $5,179 |
| 11103 Skin Biopsy | Office | 102 | 50 | $33.85 | $3,453 |
| 17110 Destruction Skin Lesion | Office | 85 | 72 | $73.57 | $6,253 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 83 | 21 | $0.74 | $61.19 |
| 99215 Office E&M - Established | Office | 59 | 50 | $115.68 | $6,825 |
| 11901 Skin | Office | 56 | 16 | $43.38 | $2,429 |
| 36415 Venipuncture Blood Collection | Office | 38 | 37 | $8.65 | $329 |
| 11104 Skin Biopsy | Office | 19 | 19 | $82.91 | $1,575 |
| 99204 Office E&M - New | Office | 16 | 16 | $66.94 | $1,071 |
| 17262 Destruction Skin Lesion | Office | 13 | 11 | $107.31 | $1,395 |
By year: 2023 $52K for 1,249 services; 2024 $72K for 2,026 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 38 | 37 | $8.65 | $329 |
Medicare prescription drug claims, 2024
In 2024, the drug Julia P Speros prescribed most often to Medicare patients was Minoxidil, with 413 prescriptions and refills. In total Julia P Speros wrote 1,690 Medicare prescriptions that cost $78K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Minoxidil Generic | 413 | 1,216 | 129 | $5,491 |
| Finasteride Generic | 323 | 944 | 102 | $2,726 |
| Ketoconazole Generic | 174 | 243 | 84 | $2,333 |
| Clobetasol Propionate Generic | 174 | 211 | 89 | $7,547 |
| Betamethasone Valerate Generic | 55 | 79 | 24 | $2,007 |
| Triamcinolone Acetonide Generic | 53 | 65 | 35 | $973 |
| Mupirocin Generic | 49 | 51 | 38 | $627 |
| Doxycycline Monohydrate Generic | 35 | 86 | 19 | $1,516 |
| Hydrocortisone Generic | 34 | 40 | 23 | $444 |
| Doxycycline Hyclate Generic | 33 | 95 | 13 | $1,256 |
| Spironolactone Generic | 32 | 96 | 11 | $696 |
| Clindamycin Phosphate Generic | 27 | 27 | Under 11 | $984 |
| Ciclopirox Generic | 27 | 32 | 16 | $961 |
| Hydroxychloroquine Sulfate Generic | 27 | 79 | Under 11 | $899 |
| Dutasteride Generic | 18 | 52 | Under 11 | $96.16 |
Brand drugs: 71 claims; generic drugs: 1,619 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julia P Speros $531 ($531 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $108.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $108 |
| Janssen Biotech, Inc. JNJ | 1 | $99.99 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $75.19 |
| Genzyme Corporation SNY | 3 | $72.37 |
| Pfizer Inc. PFE | 3 | $52.05 |
| UCB, Inc. UCB.BR | 2 | $37.83 |
| Arcutis Biotherapeutics, Inc. ARQT | 2 | $31.57 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $20.51 |
| Organon LLC OGN | 1 | $19.58 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $13.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.